FERRING PHARMACEUTICALS, INC.

Lobbying client · District of Columbia · filed 2025 to 2026

$1,240,000 Reported spend

6 Filings counted

1 Firms hired

12 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (200739), not by name.

Firms hired 1

FERRING PHARMACEUTICALS, INC. $1,240,000 6 filings

Bills named in these filings 12

HR 1878
IVF Access and Affordability Act

6 filings
HR 1670
Family Building FEHB Fairness Act

4 filings
HR 220
Veterans Infertility Treatment Act of 2025

4 filings
HR 4639
Infertility Treatment Affordability Act of 2025

4 filings
S 797
Family Building FEHB Fairness Act

4 filings
HR 4299
Protecting Patient Access to Cancer and Complex Therapies Act

3 filings
HR 3838
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fisc…

2 filings
HR 6797
Bipartisan IVF for Military Families Act

2 filings
HR 8119
HOPE with Fertility Services Act

2 filings
S 2296
National Defense Authorization Act for Fiscal Year 2026

2 filings
HCONRES 14
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth…

1 filing
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

1 filing

Reported by year 2 years

2026 $470,000 2 filings
2025 $770,000 4 filings

Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 6

HOUSE OF REPRESENTATIVES 6
SENATE 6
Health & Human Services, Dept of (HHS) 3
Commerce, Dept of (DOC) 2
U.S. Trade Representative (USTR) 2
White House Office 2

Recent filings 6 total

Q2

FERRING PHARMACEUTICALS, INC.

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $250,000 expenses · posted Jul 18, 2026

View → Q1

FERRING PHARMACEUTICALS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $220,000 expenses · posted Apr 18, 2026

View → Q4

FERRING PHARMACEUTICALS, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $290,000 expenses · posted Jan 15, 2026

View → Q3

FERRING PHARMACEUTICALS, INC.

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $160,000 expenses · posted Oct 16, 2025

View → Q2

FERRING PHARMACEUTICALS, INC.

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $160,000 expenses · posted Jul 18, 2025

View → Q1

FERRING PHARMACEUTICALS, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $160,000 expenses · posted Apr 18, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.